234 related articles for article (PubMed ID: 16224195)
1. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Ratner P; Falqués M; Chuecos F; Esbrí R; Gispert J; Peris F; Luria X; Rosales MJ
Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
4. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
Ratner P; Hampel F; Gispert J
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
[TBL] [Abstract][Full Text] [Related]
6. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
Gehanno P; Bremard-Oury C; Zeisser P
Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
13. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
Storms WW
Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
20. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
